BRINTINE Trademark

Trademark Overview

On Wednesday, October 16, 2019, a trademark application was filed for BRINTINE with the United States Patent and Trademark Office. The USPTO has given the BRINTINE trademark a serial number of 79274397. The federal status of this trademark filing is REGISTERED as of Tuesday, November 24, 2020. This trademark is owned by H. Lundbeck A/S. The BRINTINE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances acting on the central nervous system
brintine

General Information

Serial Number79274397
Word MarkBRINTINE
Filing DateWednesday, October 16, 2019
Status700 - REGISTERED
Status DateTuesday, November 24, 2020
Registration Number6202724
Registration DateTuesday, November 24, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 8, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances acting on the central nervous system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 23, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameH. Lundbeck A/S
Party Type30 - Original Registrant
Legal Entity Type65 - NOT AVAILABLE
AddressDK
Party NameH. Lundbeck A/S
Party Type20 - Owner at Publication
Legal Entity Type65 - NOT AVAILABLE
AddressDK
Party NameH. Lundbeck A/S
Party Type10 - Original Applicant
Legal Entity Type65 - NOT AVAILABLE
AddressDK

Trademark Events

Event DateEvent Description
Friday, March 22, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 22, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 22, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 22, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, March 22, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sunday, March 21, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, February 27, 2021FINAL DISPOSITION NOTICE SENT TO IB
Saturday, February 27, 2021FINAL DISPOSITION PROCESSED
Wednesday, February 24, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 24, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, September 8, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 8, 2020PUBLISHED FOR OPPOSITION
Wednesday, August 19, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 5, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 4, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 3, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 3, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, March 7, 2020REFUSAL PROCESSED BY IB
Tuesday, February 18, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, February 18, 2020REFUSAL PROCESSED BY MPU
Thursday, January 23, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, January 22, 2020NON-FINAL ACTION WRITTEN
Wednesday, January 22, 2020ASSIGNED TO EXAMINER
Friday, December 27, 2019APPLICATION FILING RECEIPT MAILED
Monday, December 23, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 19, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

brintine nervous system central acting preparations substances pharmaceutical